Oncoloxía médica
Servicio
University of Messina
Mesina, ItaliaPublicacións en colaboración con investigadores/as de University of Messina (6)
2023
2019
-
Integrin-linked kinase (ILK) and src homology 2 domain-containing phosphatase 2 (SHP2): Novel targets in EGFR-mutation positive non-small cell lung cancer (NSCLC)
EBioMedicine, Vol. 39, pp. 207-214
-
Is there room for personalized medicine in Small-Cell Lung Cancer (SCLC)? Remarkable activity of pazopanib in refractory FGFR1-amplified ED-SCLC
JCO Precision Oncology, Vol. 3, pp. 1-8
2017
-
Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer
Cancer Research, Vol. 77, Núm. 9, pp. 2213-2221
2015
-
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer
Scientific Reports, Vol. 5
2011
-
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine
Lung Cancer, Vol. 71, Núm. 2, pp. 191-198